Taclonex Topical Suspension 0.005-0.064pct Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Taclonex: Topical suspension (0.005-0.064%)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png
Taclonex Topical Suspension

What is this Medicine?

BETAMETHASONE; CALCIPOTRIENE (bay ta METH a sone; kal si poe TRYE een) is used to treat psoriasis on the scalp. It helps reduce skin redness, thickness, and scaling.

CVS Pharmacy Patient Statistics for Taclonex: Topical suspension(0.005-0.064%)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Taclonex 0.005%-0.064% Topical Suspension

NDC: 502220501
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Psoriasis

Storage Information
Do not refrigerate
Store in original container
Product should be used within 3 months after opening
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Taclonex 0.005%-0.064% Topical Suspension

Reported Side Effects for Taclonex 0.005%-0.064% Topical Suspension

Infection Incidence:
<1.0%*
Severity: MILD
Onset: DELAYED
Spider Veins Incidence:
0.1%*
Severity: MILD
Onset: DELAYED
Darkened Skin Patches Incidence:
0.1%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
0.1-1.2%*
Severity: MILD
Onset: EARLY
Inflamed Hair Follicles Incidence:
0.1-1.4%*
Severity: MILD
Onset: DELAYED
Thinning Of Skin Incidence:
0.1-1.9%*
Severity: SEVERE
Onset: DELAYED
Unusual Skin Lightening Incidence:
0.1-1.4%*
Severity: MILD
Onset: DELAYED
Paresthesias Incidence:
0.2-1.4%*
Severity: MILD
Onset: DELAYED
Skin Redness Incidence:
0.4-2.1%*
Severity: MODERATE
Onset: EARLY
Skin Irritation Incidence:
0.4-1.4%*
Severity: MILD
Onset: EARLY
Bruise Incidence:
1.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
2.3%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
2.8-7.2%*
Severity: MILD
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Taclonex

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5